The ETPN Executive Board
Up one levelShort information on the ETPN Executive Board
|
Chairperson |
|
Vice-Chairperson |
||
![]() |
![]() |
|||
| Mr. Bertrand Loubaton
|
Dr. Jürgen Simon |
|||
|
Director Pharmaceutica & Academic Research Collaboration |
Director Strategy, Head of Innovation and Cooperation |
|||
|
GE Healthcare Europe, France |
Siemens AG Healthcare, Germany |
|||
| >>> CV |
>>> CV | |||
| WG Nanodiagnostics | ||||
| Chair |
Vice Chair |
|||
![]() |
||||
| Patrick Boisseau |
Dr. Adriele Prina-Mello |
|||
| Programme Manager Nanomedicine | Nanomedicine Research Fellow |
|||
| CEA, France |
CRANN - Naughton Institute Trinity College Dublin, Ireland |
|||
| >>> CV | >>> CV |
|||
| WG Drug Delivery | ||||
| Chair |
Vice Chair |
|||
| Prof. Mike Eaton |
Prof. Costas Kirissides |
|||
| Senior Principal Scientist |
Director of Central Administration / Chairman of the Board of
Directors |
|||
| UK |
Hellas - CERTH, Greece |
|||
| >>> CV | >>> CV | |||
| Vice Chair |
||||
| Prof. Flavio Forni |
||||
| Full professor in pharmaceutical technology |
||||
| University of Modena and Reggio Emilia, Italy |
||||
| >>> CV |
||||
| WG Regenerative Medicine | ||||
| Chair |
Vice Chair |
|||
| N.N |
Dr. Cem Bozkurt |
|||
| CEO |
||||
| Cellerix, Spain |
Alvimedica Medical Technologies, Turkey |
|||
| >>> CV |
||||
| AG Regulatory Affairs |
||||
| Chair | Vice Chair |
|||
![]() |
![]() |
|||
| Dr. Joan-Albert Vericat |
Prof. Bärbel Dorbeck-Jung |
|||
| Director, Preclinical Development | Associate Professor of Legal Governance |
|||
| NOSCIRA S.A., Spain |
University of Twente, The Netherlands |
|||
| >>> CV | >>> CV |
|||
| AG IPR | AG ELSA | |||
![]() |
![]() |
|||
| Maaike van
Velzen |
Dr. Klaus-Michael Weltring | |||
| Senior Director, IP Creation - BG Healthcare | Managing Director |
|||
| Philips Intellectual Property & Standards, The Netherlands | Bioanalytik-Münster e.V., Germany |
|||
| >>> CV | >>> CV | |||







